Skip to main content

Abstract

Sjögren’s syndrome (SS) is a chronic autoimmune disease of unknown aetiology, characterized by lymphocyte infiltration of exocrine glands resulting in xerostomia and keratoconjunctivitis sicca. In more than one-third of patients, extraglandular manifestations, such as skin, lung, kidney, liver, muscle and blood vessel involvement, can occur. SS can be found alone (primary SS) or in association with other autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus and scleroderma (secondary SS). Five per cent of patients may develop B-cell lymphoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further reading

  • Fox PC, Atkinson JC, Naynski AA et al Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med 1991; 151: 1149–52.

    Article  PubMed  CAS  Google Scholar 

  • Haneji N, Nakamura T, Takiok et al. Identification of a fodrin as a candidate autoantigen in pri-mary Sjögren’s syndrome. Science 1997; 276: 604–7.

    Article  PubMed  CAS  Google Scholar 

  • Moutsopoulos HM. Sjögren’s syndrome—autoimmune epithelitis. Clin Immunol Immunopathol 1994; 72: 162–5.

    Article  PubMed  CAS  Google Scholar 

  • Moutsopoulos HM, Velthuis PJ, DeWide PCM, Kater L. Sjögren’s syndrome. In: Kater L, de la Faille HB, eds. Multisystemic Autoimmune Diseases. Amsterdam: Elsevier Science, 1995: 173–205.

    Google Scholar 

  • Talai N, Moutsopoulos HM, Kassan SS. Sjögren’s Syndrome. Clinical and Immunological Aspects. Berlin: Springer, 1987.

    Book  Google Scholar 

  • Tzioufas AG, Moutsopoulos HM. Sjögren’s syndrome. In: Klippel JH, Dieppe PA, eds. Rheumatology. London: Mosby, 1993, 6: 32. 1–12.

    Google Scholar 

  • Vivino FB, Al-Hashimi I, Khan Z et al Pilocarpine tablets for the treatment of dry mouth and dry eyes symptoms in patients with Sjögren’s syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92–01 Study group. Arch Intern Med 1999; 159: 174–81.

    Article  PubMed  CAS  Google Scholar 

  • Vlachoyiannopoulos PG, Moutsopoulos HM. Therapy of Sjögren’s syndrome. In: van de Putte LBA, Furst DE, Williams WJ, van Riel PLCM, eds. Therapy of Systemic Rheumatic Disorders. New York: Marcel Dekker, 1998: 615–28.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Tzioufas, A.G., Moutsopoulos, H.M. (2003). Sjögren’s syndrome. In: Katsambas, A.D., Lotti, T.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07131-1_87

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-07131-1_87

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-05657-4

  • Online ISBN: 978-3-662-07131-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics